While cancer stem cells or cancer-initiating cells may contribute to radiation resistance of breast cancer26, endocrine resistance and HER-2 targeted therapy resistance may involve the loss of estrogen receptor (ER) alpha expression24 and incomplete blockade of the HER receptors23. This evidence concerns the gene ESR1 and cancer.